|
CA2264819C
(en)
*
|
1996-09-04 |
2010-03-23 |
Intertrust Technologies Corp. |
Trusted infrastructure support systems, methods and techniques for secure electronic commerce, electronic transactions, commerce process control and automation, distributed computing, and rights management
|
|
TW200801012A
(en)
|
2006-04-26 |
2008-01-01 |
Piramed Ltd |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
|
TWI498332B
(zh)
*
|
2006-04-26 |
2015-09-01 |
Hoffmann La Roche |
作為pi3k抑制劑之嘧啶衍生物及相關製備方法、醫藥組合物、用途、套組及產物
|
|
RU2470936C2
(ru)
*
|
2006-12-07 |
2012-12-27 |
Дженентек, Инк. |
Соединения-ингибиторы фосфоинозитид 3-киназы и способы применения
|
|
MX2009005950A
(es)
|
2006-12-07 |
2009-10-12 |
Genentech Inc |
Compuestos inhibidores de fosfoinositido 3-quinasas y metodos de uso.
|
|
AU2008218806B2
(en)
*
|
2007-02-20 |
2011-12-01 |
Novartis Ag |
Imidazoquinolines as dual lipid kinase and mTOR inhibitors
|
|
US7893060B2
(en)
*
|
2007-06-12 |
2011-02-22 |
F. Hoffmann-La Roche Ag |
Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
|
|
EP2205242B1
(en)
*
|
2007-09-12 |
2015-04-15 |
Genentech, Inc. |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
|
|
CA2704711C
(en)
|
2007-09-24 |
2016-07-05 |
Genentech, Inc. |
Thiazolopyrimidine p13k inhibitor compounds and methods of use
|
|
JP5348725B2
(ja)
*
|
2007-10-25 |
2013-11-20 |
ジェネンテック， インコーポレイテッド |
チエノピリミジン化合物の製造方法
|
|
US20110230464A1
(en)
*
|
2007-10-26 |
2011-09-22 |
Paul Goldsmith |
Purine derivatives useful as p13 kinase inhibitors
|
|
GB0721095D0
(en)
*
|
2007-10-26 |
2007-12-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
CA2723987C
(en)
|
2008-05-14 |
2019-06-11 |
Agriculture Victoria Services Pty Ltd |
Use of angiogenin or angiogenin agonists for treating diseases and disorders
|
|
CA2721851A1
(en)
*
|
2008-05-30 |
2009-12-03 |
Genentech, Inc. |
Purine pi3k inhibitor compounds and methods of use
|
|
CA2729045A1
(en)
*
|
2008-07-31 |
2010-02-04 |
Philippe Bergeron |
Pyrimidine compounds, compositions and methods of use
|
|
TWI378933B
(en)
|
2008-10-14 |
2012-12-11 |
Daiichi Sankyo Co Ltd |
Morpholinopurine derivatives
|
|
AU2009304596A1
(en)
|
2008-10-17 |
2010-04-22 |
Akaal Pharma Pty Ltd |
S1P receptors modulators
|
|
WO2010043000A1
(en)
|
2008-10-17 |
2010-04-22 |
Akaal Pharma Pty Ltd |
S1p receptors modulators and their use thereof
|
|
AU2009314544C1
(en)
*
|
2008-11-11 |
2015-11-12 |
Xcovery Holding Company Llc |
PI3K/mTOR kinase inhibitors
|
|
WO2010059788A1
(en)
*
|
2008-11-20 |
2010-05-27 |
Genentech, Inc. |
Pyrazolopyridine pi3k inhibitor compounds and methods of use
|
|
WO2010078897A1
(en)
*
|
2009-01-08 |
2010-07-15 |
Merck Patent Gmbh |
Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
|
|
EA024252B1
(ru)
*
|
2009-01-08 |
2016-08-31 |
Кьюрис, Инк. |
Ингибиторы фосфоинозитид-3-киназ с цинксвязывающей группой
|
|
JP5709766B2
(ja)
*
|
2009-03-12 |
2015-04-30 |
ジェネンテック， インコーポレイテッド |
造血器腫瘍の治療のためのホスホイノシチド３キナーゼ阻害剤化合物と化学療法剤の併用
|
|
WO2010103130A2
(en)
*
|
2009-03-13 |
2010-09-16 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Novel bicyclic heterocycles
|
|
CN102361878A
(zh)
|
2009-03-24 |
2012-02-22 |
住友化学株式会社 |
用于制备硼酸酯化合物的方法
|
|
TW201038567A
(en)
|
2009-03-27 |
2010-11-01 |
Pathway Therapeutics Ltd |
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
|
BRPI1009022A2
(pt)
*
|
2009-05-27 |
2016-03-08 |
Hoffmann La Roche |
"composto, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de um composto, método para tratamento de uma doença ou transtorno e kit"
|
|
US8158625B2
(en)
|
2009-05-27 |
2012-04-17 |
Genentech, Inc. |
Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
|
|
US20100331305A1
(en)
*
|
2009-06-24 |
2010-12-30 |
Genentech, Inc. |
Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use
|
|
CA2767008C
(en)
|
2009-07-07 |
2018-01-30 |
Pathway Therapeutics, Inc. |
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
|
|
EP2461813A4
(en)
*
|
2009-08-05 |
2014-02-19 |
Univ Wake Forest Health Sciences |
COMPOSITIONS AND METHODS FOR APOPTOSIS-TREATMENT IN PROSTATE MAINTENANCE CELLS
|
|
NZ598220A
(en)
|
2009-08-17 |
2014-02-28 |
Intellikine Llc |
Heterocyclic compounds and uses thereof
|
|
MX2012002059A
(es)
*
|
2009-08-20 |
2012-04-19 |
Karus Therapeutics Ltd |
Compestos heterociclicos triciclicos como inhibidores de fosfoionositida 3-quinasa.
|
|
JP2013504325A
(ja)
*
|
2009-09-09 |
2013-02-07 |
アビラ セラピューティクス， インコーポレイテッド |
Ｐｉ３キナーゼインヒビターおよびその使用
|
|
EP2475367A1
(en)
*
|
2009-09-10 |
2012-07-18 |
Centre National De La Recherche Scientifique |
NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
|
|
US8263633B2
(en)
|
2009-09-28 |
2012-09-11 |
F. Hoffman-La Roche Ag |
Benzoxepin PI3K inhibitor compounds and methods of use
|
|
WO2011049625A1
(en)
|
2009-10-20 |
2011-04-28 |
Mansour Samadpour |
Method for aflatoxin screening of products
|
|
NZ599830A
(en)
|
2009-11-05 |
2014-08-29 |
Rhizen Pharmaceuticals Sa |
Novel kinase modulators
|
|
EP2499143B1
(en)
*
|
2009-11-12 |
2016-03-16 |
F.Hoffmann-La Roche Ag |
N7-substituted purine and pyrazolopyrimidine compounds, compositions and methods of use
|
|
JP5579864B2
(ja)
*
|
2009-11-12 |
2014-08-27 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
Ｎ−９−置換プリン化合物、組成物及び使用の方法
|
|
US8633183B2
(en)
*
|
2010-01-26 |
2014-01-21 |
Boehringer Ingelheim International Gmbh |
5-alkynyl-pyrimidines
|
|
EP2539337A1
(en)
|
2010-02-22 |
2013-01-02 |
F. Hoffmann-La Roche AG |
Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use
|
|
UY33304A
(es)
*
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
|
ES2536780T3
(es)
|
2010-07-14 |
2015-05-28 |
F. Hoffmann-La Roche Ag |
Compuestos de purina selectivos para I3 p110 delta, y métodos de uso
|
|
TW201500358A
(zh)
|
2010-12-16 |
2015-01-01 |
赫夫門羅氏藥廠股份有限公司 |
三環ｐｉ３ｋ抑制劑化合物及其使用方法
|
|
EP2667874A4
(en)
*
|
2011-01-27 |
2014-07-30 |
Univ Princeton |
MTOR KINASE HEMMER AS ANTIVIRUS AGENT
|
|
RU2013138835A
(ru)
*
|
2011-02-09 |
2015-03-20 |
Ф. Хоффманн-Ля Рош Аг |
Гетероциклические соединения в качестве ингибиторов pi3 киназы
|
|
US9090628B2
(en)
|
2011-03-21 |
2015-07-28 |
Genentech, Inc. |
Benzoxazepin compounds selective for PI3K P110 delta and methods of use
|
|
TWI572599B
(zh)
|
2011-03-28 |
2017-03-01 |
Ｍｅｉ製藥公司 |
（α－經取代之芳烷胺基及雜芳烷胺基）嘧啶基及１，３，５－三基苯并咪唑，其醫藥組合物及其在治療增生性疾病之用途
|
|
WO2012135571A1
(en)
|
2011-04-01 |
2012-10-04 |
Curis, Inc. |
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
|
|
PH12013502240B1
(en)
|
2011-05-04 |
2018-06-27 |
Rhizen Pharmaceuticals Sa |
Novel compounds as modulators of protein kinase
|
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
|
KR101255939B1
(ko)
*
|
2011-05-31 |
2013-04-23 |
동화약품주식회사 |
4-(1ｈ-인다졸-6-일아미노)-ｎ-아이소프로필-2-(메틸티오)피리미딘-5-카르복스아미드 화합물 또는 이의 약학적으로 허용가능한 염을 포함하는 당뇨병 예방 또는 치료용 조성물
|
|
CA2849331A1
(en)
*
|
2011-10-13 |
2013-04-18 |
Genentech, Inc. |
Treatment of pharmacological-induced hypochlorhydria
|
|
HK1202333A1
(en)
*
|
2011-11-11 |
2015-09-25 |
Intellikine, Llc |
Combination of kinase inhibitors and uses thereof
|
|
CN102643272B
(zh)
*
|
2011-12-30 |
2015-03-11 |
沈阳药科大学 |
新的噻吩并[3,2-d]嘧啶类化合物
|
|
GB201204125D0
(en)
|
2012-03-08 |
2012-04-25 |
Karus Therapeutics Ltd |
Compounds
|
|
FR2988722B1
(fr)
|
2012-04-03 |
2014-05-09 |
Sanofi Sa |
Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
|
|
US9499561B2
(en)
|
2012-04-10 |
2016-11-22 |
Shanghai Yingli Pharmaceutical Co., Ltd. |
Fused pyrimidine compound, and preparation method, intermediate, composition, and uses thereof
|
|
DK2838533T3
(da)
|
2012-04-16 |
2017-11-27 |
Univ Case Western Reserve |
Sammensætninger og fremgangsmåder til at modulere 15-pgdh-aktivitet
|
|
US9801863B2
(en)
|
2012-04-16 |
2017-10-31 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
|
|
JP5663699B2
(ja)
*
|
2012-05-07 |
2015-02-04 |
キッセイ薬品工業株式会社 |
ピラゾール誘導体及びその医薬用途
|
|
AU2013204740C1
(en)
|
2012-05-10 |
2015-10-01 |
Agriculture Victoria Services Pty Ltd |
Methods of treating cancer using angiogenin or an angiogenin agonist
|
|
KR20160027219A
(ko)
|
2012-05-23 |
2016-03-09 |
에프. 호프만-라 로슈 아게 |
내배엽 및 간세포를 수득하고 사용하는 조성물 및 방법
|
|
BR112014028376A2
(pt)
|
2012-06-08 |
2018-04-24 |
Hoffmann La Roche |
métodos para o tratamento de um distúrbio hiperproliferativo, para a determinação dos compostos, para monitorar, para optimizar a eficácia terapêutica e de identificação de um biomarcador; formulação farmacêutica; utilização de uma combinação terapêutica e de gdc-0032, artigo de manufatura, produto e invenção
|
|
RS56494B1
(sr)
|
2012-07-04 |
2018-01-31 |
Rhizen Pharmaceuticals S A |
Selektivni inhibitori pi3k delta
|
|
BR112015002493A8
(pt)
*
|
2012-08-30 |
2019-07-30 |
Hoffmann La Roche |
composto, composição farmacêutica, processo para a preparação de uma composição farmacêutica, kit e uso de um composto”
|
|
US20150258127A1
(en)
|
2012-10-31 |
2015-09-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for preventing antiphospholipid syndrome (aps)
|
|
IN2015DN03235A
(https=)
|
2012-11-07 |
2015-10-02 |
Karus Therapeutics Ltd |
|
|
RU2015148359A
(ru)
*
|
2013-04-12 |
2017-05-15 |
Асана Биосайенсис, Ллк |
Хиназолины и азахиназолины - двойные ингибиторы путей ras/raf/mek/erk и pi3k/akt/pten/mtor
|
|
PT2994465T
(pt)
|
2013-05-10 |
2018-10-25 |
Karus Therapeutics Ltd |
Novos inibidores de histona desacetilase
|
|
DE102013008118A1
(de)
*
|
2013-05-11 |
2014-11-13 |
Merck Patent Gmbh |
Arylchinazoline
|
|
WO2014203129A1
(en)
|
2013-06-19 |
2014-12-24 |
Olema Pharmaceuticals, Inc. |
Combinations of benzopyran compounds, compositions and uses thereof
|
|
EP3053926B1
(en)
|
2013-09-30 |
2018-08-08 |
Shanghai Yingli Pharmaceutical Co. Ltd. |
Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereof
|
|
AU2014342811B2
(en)
|
2013-10-15 |
2019-01-03 |
Board Of Regents Of The University Of Texas System |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
CN104557872B
(zh)
|
2013-10-16 |
2017-05-24 |
上海璎黎药业有限公司 |
稠合杂环化合物、其制备方法、药物组合物和用途
|
|
US9452986B2
(en)
|
2014-02-06 |
2016-09-27 |
Abbvie Inc. |
6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
|
|
GB201402431D0
(en)
|
2014-02-12 |
2014-03-26 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201419264D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201419228D0
(en)
|
2014-10-29 |
2014-12-10 |
Karus Therapeutics Ltd |
Compounds
|
|
CN107921025A
(zh)
|
2015-03-08 |
2018-04-17 |
卡斯西部储备大学 |
用于治疗纤维症的短链脱氢酶活性的抑制剂
|
|
US20180057505A1
(en)
*
|
2015-03-20 |
2018-03-01 |
Vertex Pharmaceuticals Incorporated |
Bicyclic heteroaryl compounds useful as inhibitors of the par-2 signaling pathway
|
|
AR104068A1
(es)
|
2015-03-26 |
2017-06-21 |
Hoffmann La Roche |
Combinaciones de un compuesto inhibidor de fosfoinosítido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cáncer
|
|
HK1250161B
(en)
*
|
2015-03-30 |
2020-05-15 |
Daiichi Sankyo Company, Limited |
6-morpholinyl-2-pyrazolyl-9h-purine derivatives and their use as pi3k inhibitors
|
|
AU2016248080A1
(en)
*
|
2015-04-14 |
2017-11-02 |
Board Of Regents Of The University Of Texas System |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
HK1249866A1
(zh)
|
2015-06-29 |
2018-11-16 |
豪夫迈‧罗氏有限公司 |
用他塞利昔布进行治疗的方法
|
|
GB201514751D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds
|
|
GB201514760D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds and method of use
|
|
GB201514758D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Formulation
|
|
GB201514754D0
(en)
|
2015-08-19 |
2015-09-30 |
Karus Therapeutics Ltd |
Compounds
|
|
SG11201804901WA
(en)
|
2015-12-22 |
2018-07-30 |
SHY Therapeutics LLC |
Compounds for the treatment of cancer and inflammatory disease
|
|
CN107098846B
(zh)
*
|
2016-02-26 |
2020-10-09 |
中国医学科学院药物研究所 |
N-酰基磺酰胺类FBPase抑制剂、其制备方法、药物组合物及用途
|
|
US10947225B2
(en)
|
2016-05-11 |
2021-03-16 |
Emory University |
Phosphotidylinositol 3-kinase inhibitors
|
|
MX394560B
(es)
|
2016-06-01 |
2025-03-24 |
Bayer Pharma AG |
Uso de indazoles sustituidos para el tratamiento y la prevencion de enfermedades en animales.
|
|
WO2018057588A1
(en)
*
|
2016-09-21 |
2018-03-29 |
Vertex Pharmaceuticals Incorporated |
Furo[3,2-b]pyridine compounds useful as inhibitors of the par-2 signaling pathway
|
|
TW201825465A
(zh)
|
2016-09-23 |
2018-07-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
TW201813963A
(zh)
|
2016-09-23 |
2018-04-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
TW201815787A
(zh)
|
2016-09-23 |
2018-05-01 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
US11304953B2
(en)
|
2017-05-23 |
2022-04-19 |
Mei Pharma, Inc. |
Combination therapy
|
|
EA201992780A1
(ru)
*
|
2017-06-21 |
2020-06-02 |
ШАЙ ТЕРАПЬЮТИКС ЭлЭлСи |
Соединения, которые взаимодействуют с суперсемейством ras, для лечения рака, воспалительных заболеваний, ras-опатий и фиброзного заболевания
|
|
KR20200041358A
(ko)
|
2017-08-14 |
2020-04-21 |
메이 파마, 아이엔씨. |
병용 요법
|
|
CN109796465B
(zh)
*
|
2017-11-16 |
2020-07-14 |
华中科技大学同济医学院附属协和医院 |
靶向pet显像化合物、包含该化合物的显象剂及其制备方法和用途
|
|
CA3102279A1
(en)
|
2018-06-01 |
2019-12-05 |
Cornell University |
Combination therapy for pi3k-associated disease or disorder
|
|
CN113164466B
(zh)
|
2018-09-11 |
2025-07-08 |
柯瑞斯公司 |
使用具有锌结合部分的磷酸肌醇3-激酶抑制剂的联合治疗
|
|
ES2987854T3
(es)
|
2018-10-12 |
2024-11-18 |
Board Of Regents Of Theuniversity Of Nebraska |
Inhibidores de fosfodiesterasa
|
|
US12391705B2
(en)
|
2018-12-19 |
2025-08-19 |
Shy Therapeutics, Llc |
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
|
GB201909468D0
(en)
|
2019-07-01 |
2019-08-14 |
Karus Therapeutics Ltd |
Compounds for treating cancer
|
|
TWI885039B
(zh)
|
2020-01-13 |
2025-06-01 |
美商邊際分析公司 |
經取代吡唑并嘧啶及其用途
|
|
US20240150358A1
(en)
*
|
2020-06-03 |
2024-05-09 |
Kineta, Inc. |
Purines and methods of their use
|
|
CA3198317A1
(en)
*
|
2020-11-10 |
2022-05-19 |
Kevin J. Wilson |
Compounds and uses thereof
|
|
WO2022184152A1
(zh)
*
|
2021-03-03 |
2022-09-09 |
劲方医药科技(上海)有限公司 |
稠环取代的六元杂环化合物及其制法和用途
|
|
WO2022266251A1
(en)
*
|
2021-06-16 |
2022-12-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions for treatment of psoriasis
|
|
CN115916775B
(zh)
*
|
2021-06-22 |
2025-02-07 |
成都硕德药业有限公司 |
Atr抑制剂及其用途
|
|
EP4410795A4
(en)
*
|
2021-09-30 |
2025-10-01 |
Hanmi Pharmaceutical Co Ltd |
PIKFYVE KINASE INHIBITOR
|
|
CN115991716B
(zh)
*
|
2021-10-19 |
2025-10-17 |
中国药科大学 |
嘧啶并环类化合物及其衍生物、制备方法、药物组合物和应用
|
|
US20250084078A1
(en)
*
|
2022-01-04 |
2025-03-13 |
Genfleft Therapeutics (Shanghai) Inc. |
Fused ring-substituted six-membered heterocyclic compound, and preparation method therefor and use thereof
|
|
CN114539293B
(zh)
*
|
2022-02-24 |
2023-09-22 |
广东晨康生物科技有限公司 |
一种噻吩并嘧啶类化合物或其药学上可接受的盐及其制备方法和应用
|
|
AR129299A1
(es)
|
2022-05-11 |
2024-08-07 |
Foghorn Therapeutics Inc |
Compuestos para modular complejos de factores asociados a brg1 o brm (baf)
|
|
CN117164590B
(zh)
*
|
2022-05-25 |
2026-03-17 |
沈阳药科大学 |
稠合嘧啶类衍生物及其应用
|
|
CA3266173A1
(en)
*
|
2022-10-26 |
2024-05-02 |
Boehringer Ingelheim International Gmbh |
HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING
|